Literature DB >> 14512605

Good and bad amyloid antibodies.

Mark P Mattson, Sic L Chan.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14512605     DOI: 10.1126/science.301.5641.1847

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

1.  A lifetime of dedication to the old in his Kentucky home.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2010-07-08       Impact factor: 3.843

Review 2.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

Review 3.  Surface plasmon resonance for the analysis of beta-amyloid interactions and fibril formation in Alzheimer's disease research.

Authors:  Marie-Isabel Aguilar; David H Small
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 4.  Commentary: proteooxidotoxic process of aggregation.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2011-05-19       Impact factor: 3.843

Review 5.  Is passive immunization for Alzheimer's disease 'alive and well' or 'dead and buried'?

Authors:  Gregory A Jicha
Journal:  Expert Opin Biol Ther       Date:  2009-04       Impact factor: 4.388

6.  Monoclonal antibodies against Aβ42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain.

Authors:  Asa Hatami; Ricardo Albay; Sanaz Monjazeb; Saskia Milton; Charles Glabe
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

7.  Active beta-amyloid immunization restores spatial learning in PDAPP mice displaying very low levels of beta-amyloid.

Authors:  Guiquan Chen; Karen S Chen; Dione Kobayashi; Robin Barbour; Ruth Motter; Dora Games; Stephen J Martin; Richard G M Morris
Journal:  J Neurosci       Date:  2007-03-07       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.